Financials

  • Market Capitalization 360.81 M
  • Employee 533
  • Founded 2002
  • CEO N/A
  • Website www.vandapharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000HT5MG6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.36
Price to sales ratio
2.41

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3147
FENC
Fennec Pharmaceuticals Inc. - Common Stock
10.75 USD+2.48%-0.46%+18.78%+21.47%373.42 M USD
3166
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.65 USD-3.53%-1.06%+2.65%+3.33%365.13 M USD
3198
PRLD
Prelude Therapeutics Incorporated - Common Stock
4.44 USD-7.69%-11.55%-3.48%+448.15%353.63 M USD
3202
FATE
Fate Therapeutics, Inc. - Common Stock
3.02 USD-2.58%-0.33%+44.50%+162.61%352.01 M USD

Frequently asked questions about Vanda Pharmaceuticals Inc. - Common Stock

What is the Vanda Pharmaceuticals Inc. - Common Stock stock price today?

The current price of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) is 6. Over the past 24 hours, the stock has changed by -3.85%. Follow the VNDA chart for real-time price dynamics.

What is the stock ticker of Vanda Pharmaceuticals Inc. - Common Stock?

Vanda Pharmaceuticals Inc. - Common Stock trades under the ticker VNDA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Vanda Pharmaceuticals Inc. - Common Stock stock going up?

VNDA has changed by -4.46% over the last week, +1.18% over the last month, and +8.50% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Vanda Pharmaceuticals Inc. - Common Stock net income for the last quarter?

Vanda Pharmaceuticals Inc. - Common Stock reported net income of -48.57 M for the last quarter. The previous quarter showed -141.19 M, which means net income changed by +65.60%.

How many employees does Vanda Pharmaceuticals Inc. - Common Stock have?

As of the latest available data, Vanda Pharmaceuticals Inc. - Common Stock has 533 employees. Workforce size can provide additional context about the company's scale and operations.

What is Vanda Pharmaceuticals Inc. - Common Stock EBITDA?

Vanda Pharmaceuticals Inc. - Common Stock EBITDA is -47.96 M, and its EBITDA margin is -92.74%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Vanda Pharmaceuticals Inc. - Common Stock stock?

You can buy Vanda Pharmaceuticals Inc. - Common Stock (VNDA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Vanda Pharmaceuticals Inc. - Common Stock stock?

Investing in Vanda Pharmaceuticals Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VNDA chart and related analysis on metatrader.com as part of your research.

News